Topic table

Topic Table - overview

LASA has data available on many different topics in various functional domains. To make it easier for those who would like to make use of LASA data, the topic table below provides an overview of the topics for which data are available in LASA, the corresponding data file number, and the measurement cycles (waves) in which the topic is included. When clicking on the topic name, you will be re-directed to a page with more detailed documentation on the specific topic. This table is a concatenation of all theme tables which can be shown by clicking on the menu-items behind “themes”. 

Legend

UC: Under Construction

*: in wave C, the same interview was administered to both respondents and proxies (processed in LASA6xx-files)

**: not yet documented

Note I: some of the data are not yet available (in red)

Note II: the table is also horizontally scrollable. So, if e.g. the last column does not show, it can be made visible by sliding the horizontal scroll bar at the bottom of the table forwards. In the desktop version you can also click on an empty space in the table and use the right and left keys on the key board to move the table backwards and forwards

Note III: investigations for the K-wave will take place in 2021-2022. Results for this wave will be made available in the course of 2022 or later.

LASA-WAVE BCDE2BFGH3BMBIJK
Cohort 1
Cohort 2
Cohort 3
Migrant Cohort
THEME BIOMATERIAL
Blood collection
and overview
(routine)
measurements

– Response blood
sampling / DNA
Date blood
sampling

850




851
850




851















851





850




851






850




851























Routine
measurements
(Albumin and
cholesterol)

860860860860860
Adiponectin, leptin
and ghrelin
879
Apolipoprotein E
(ApoE)
– Phenotyping
– Genotyping


870








870















Cholesterol,
triglycerides and
fructosamin

867
COLIA1 (Collagen
type I α1 Sp1
polymorphism in
LASA)

871
Cortisol (total
plasma cortisol,
corticosteroid
binding globuline,
salivary cortisol)
– Serum cortisol
– Salivary cortisol












864












880/
881/
882






















































BCDE2BFGH3BMBIJK
Hair cortisol
(LASA ancillary study)

Genetic
polymorphisms
(VDR, GR, etc)
– Vit D Receptors
– Haplotypes








872
873












































GWAS data
XXXX
Exome Chip
XX
Homocysteine,
vitamin B12, MMA

866
Bone-related
hormones and
bone turnover

862
Inflammation
factors
– Pro-inflammatory
cytokine
Interleukin-6 (IL-6)
– Acute-phase
proteins C-reactive
protein (CRP)
– A1-
antichymotrypsin
(ACT)
861861861
Serum Amyloid P
component (SAP)

868
Serum 25-hydroxy-
vitamin D (25(OH)D) and
parathyroid
hormone (PTH)

862
862862862
Sex hormones
863
Thyroid function
865
Vitamin K status
869
THEME CARE
Attitudes about
care
032

112















112



112



112



112



112



112



112



112

175


112

175
Filial
responsibility
expectations IM

– scaled








132



332
132



332




























132



332




Vignettes about
help


– total scores






074


274






























Providing careBCDE2BFGH3BMBIJK
Providing
assistance with
personal/
household care

142142142142142142142142142
Family caregiving
to older adults
(LASA ancillary study)
X
Use of careBCDE2BFGH3BMBIJK
Use of personal/
household care

-tel.proxy*

-tel.respondent*
033




033


603

603
033


603

703
033


603

703
033




033


603

703
033


603

703
033


603

703
033




033




033


603

703
033


603

703
033
Care evaluation033033033033033033033033033033033033033
Use of nursing
care

-tel. proxy*

-tel. respondent*



































033


603

703
033




033




033


603

703
033


603

703
033
Use of transport/
admin. care

-tel.proxy*

-tel.respondent*



































033


603

703










033


603

703
033


603

703
033
Personal budget
(PGB)
033
Perceived
control of care
033033033033033033
Satisfaction with
care
033033033033033033033033033033033033033
Need for care033033033033033033033033
Aggr. variables
care network
233
Use of respite care by R
(for partner)
139139139
Perceived
control in health
care and scale
(LASA ancillary study)
       X   
Transitions in
care**
(LASA ancillary study)
Adaptations
and facilities
BCDE2BFGH3BMBIJK
Adaptations in
the house


(see Theme SOC)
Use of
assistive devices or
assistence


(see Theme PHY)
Contact with
services
BCDE2BFGH3BMBIJK
Contact with
health and social
services
044044044044044044044044044044044044044
Hospital
admission

-tel.proxy*

-tel.respondent*
045




045


603

603
045


603

703
045


603

703
045




045


603

703
045


603

703
045


603

703
045




045




045


603

703
045


603

703
045
Outpatient
contact with
med. specialists
last 6 months

– specification of
specialist
045




245
045




245
045




245
045




245
045




245
045




245
045




245
045




245
045




245
045




245
045




245
045




245
045




245
Health care in
country of origin

068
Needs
assessment
BCDE2BFGH3BMBIJK
Needs
assessment
(WVG/Wmo/
AWBZ/Zvw/
Wlz)IM

-tel.proxy*

-tel.proxy*

-tel.respondent*

-tel.respondent*








































189























189

610



710

177

178

189



611



711
177

178

189



611



711
























177

178

189



611

710

711
177

178

189

610

611

710

711
177

178

189
Residential care
after attrition**
            
End of life
care and
preferences
BCDE2BFGH3BMBIJK
Advance
Directives


-tel.respondent*








093



709










195



195




195











195



195



195

Feelings and
wishes about
life and death
127127127
Decisions in eol
situations
148
General eol goals
(see also
Subj. life exp.
)
094094094094094094
Last wishes146 –
Advance Care
Planning (ACP)
108
Opinions about
euthanasia and
end-of-life
(eol) pill
122122122122122122122122122122122122
End-of-life care:
interviews with
proxies
(LASA ancillary study)
   X  X     
THEME COGNITIVE
Intelligence
and cognition
BCDE2BFGH3BMBIJK
Crystallized
intelligence (GIT ©)

– total scores



037


237









037


237












037


237






Fluid intelligence
(RAVEN)

– scaled

Evaluation
RAVEN
022


222


024
022


222


022


222


022


222


022


222


022


222


022


222
































Head trauma

– tel. proxy*

– tel. respondent*








035

602

702
035

602

702




035

602

702
035

602

702
035

602

702










035

602

702
035

602

702
035
Information
processing speed
(Coding task)
155155155155155155155155155155155155
Mini-Mental
State
Examination
(MMSE)

– MMSE scaled

– MMSE
subtraction/
spelling

– tel. respondent*

– tel. respondent:
scaled
021




221

421






021




221

421






021




221

421




707

907
021




221

421




707

907
021




221

421






021




221

421




707

907
021




221

421




707

907
021




221

421




707

907
021




221

421






021




221

421






021




221

421




707

907
021




221

421




707

907
021




221

421
Informant
Quest. of cogn.
decline (IQCODE)
– tel. proxy*






607



607



607






607



607



607









607



607
Executive
functioning
BCDE2BFGH3BMBIJK
Verbal fluency165165165165165165
Executive functioning
(Digit span)
166020166166166
MemoryBCDE2BFGH3BMBIJK
Everyday
memory
023023
Episodic
memory (15WT)

– constructed
156


356
156


356
156


356
156


356
156


356
156


356
156


356
156


356
156


356



156


356
156


356
156


356
Memory complaints021021021021021021021021021021021021021
Metamemory

– scaled
124

324
124

324
124

324




















Memory partner139139139139139139139139
DementiaBCDE2BFGH3BMBIJK
Dementia
(probable)
XXXXXXXX
Dementia parents

– tel. respondent*




092

708


092

















Dementia partner139139139139139139139139
 
THEME DEMOGRAPHIC
General
variables
BCDE2BFGH3BMBIJK

(Non-)response*


more detailed
non-response
*

z002

002
z002

002

z002

002
z002

002
z002

002
z002

002
z002

002
z002

002
z002

002


002
z002

002

z002

002
z002

002
Age at interview*z008z008z008z008z008z008z008z008z008mb008z008z008z008
Time of
measurement*
z008z008z008z008z008z008z008z008z008mb008z008z008z008
Sex*1z004z004z004mb004
Education1z004z004z004mb004
Nationality*1z004z004z004mb004
Ethnicity*1z004z004z004mb004
Weight factors5   
MortalityBCDE2BFGH3BMBIJK
Mortality dataz990z990z990z990z990z990z990z990z990z990z990z990
Mortality and
cause of death
– Specified
z991

z992
z991

z992
z991

z992
z991

z992
z991

z992
z991

z992
z991

z992
z991

z992
z991

z992


z991

z992
z991

z992
z991

z992
GeographyBCDE2BFGH3BMBIJK
Urbanization2z095z095z095z095z095z095z095z095z095mb095z095z095z095
History of
domestic
addresses*
z052z052z052z052z052z052z052z052z052z052z052z052
  
Living
arrangements
BCDE2BFGH3BMBIJK
Household
composition
*IM
011011011011011011011011011011011011011
Housing
characteristics
IM

see Theme Social
Marital and
partner status
z010

z010
601
601
z010
601
701
z010
601
701
z010

z010
601
701
z010
601
701
z010
601
701
z010

mb010

z010
601
701
z010
601
701
z010
  
Religion3BCDE2BFGH3BMBIJK
Church affiliationz038z038z038z038z038038
Church
attendance
z038z038z038z038z038z038z038038z038038038
  
Socio-economic
status
BCDE2BFGH3BMBIJK
Occupation4016016016016016016016016016016016016016
Income

– Income
specification
017

217
017

017

017

017

017

017

017

017

017

017

017017
Income decline /
evaluation
019019019019019019019019019019019019019
Health
insurance
*
018
  
THEME EMOTIONAL
ADHDBCDE2BFGH3BMBIJK
ADHD
(LASA ancillary study)
– constructed












179

379












  
AnxietyBCDE2BFGH3BMBIJK
Anxiety symptomsIM

– scaled
026

226
026

226
026

226
026

226


026

226
026

226
026

226
026

226
026

226
026

226
026

226
026

226
Anxiety diagnosesXXXXXXXX
Posttraumatic stress (PTSD)
– scaled




091

291
091

291


















DepressionBCDE2BFGH3BMBIJK
Depressive
symptoms
– scaled

– tel. proxy*
– tel. respondent*
– tel. respondent:
scaled
025

225




025

225


606
606

025

225


606
706
906
025

225


606
706
906
025

225




025

225



706
906
025

225



706
906
025

225



706
906
025

225




025

225




025

225



706
906
025

225



706
906
025

225
Depression
diagnoses
XXXXXXXXXXX
Depressive symptoms
and
food-related behaviour
(LASA ancillary study)
 
Mental health problems
and
food-related behaviour
(LASA ancillary study)
 
  
Evaluation of lifeBCDE2BFGH3BMBIJK
Important aspects
of life
110110110110110110110110110110110110
Satisfaction
with life and
happiness

– ‘happiness-line’
110



110



110



094
110



110



110



110



110




110








110



110



110

>

Valuation of life
– scaled



137
337

137
337






Generativity802802
  
Personality traitsBCDE2BFGH3BMBIJK
Self-esteem
– scaled
027
027
227
027
227
027
227
027
227
027
227
027
227
027
227
027
227

027
227
027
227
027
227
Mastery
– scaled
027
227
027
227
027
227
027
227
027
227
027
227
027
227
027
227
027
227
027
227
027
227
027
227
027
227
Perceived
self-efficacy
– scaled
028

228
028

228
028

228
028

228
028

228
028

228
028

228
028

228
028

228


028

228
028

228
027

227
Neuroticism and
social inadequacy
– scaled
123

323
123

323
123

323
123

323
123

323






123

323








Meta-emotion029 143– 
Humor
– scaled
111
311

111
311









General self-
regulation (GSR)
– scaled












149

349
149

349










  
(In)dependenceBCDE2BFGH3BMBIJK
Investment in
independence
144144144144144144
Singing and musicBCDE2BFGH3BMBIJK
Singing and making music103103103
Religiousness1BCDE2BFGH3BMBIJK
Gerotranscendence
(Cosmic
transcendence)
– scaled



038


238
038


238
038


238
038


238
038


238





















Orthodoxy
– scaled

– scaled



038
238


038


038

138
338
038


038


038


038


038





038


038


038



Praying038038038038038038038038038038038
Salience of
religion
– scaled

– tel. respondent*
110



110
038
238


608
110
038
238


110
038
238


110
038
238


110



110



110



110







110



110



110
Religious coping105105
SexualityBCDE2BFGH3BMBIJK
Sexuality120120120120120
Gender identity**804804
SleepBCDE2BFGH3BMBIJK
Sleep quality
– scaled
117
317
117
317
117
317
117
317
117
317
117
317
117
317
117
317
117
317

117
317
117
317
117
Stress and
stressors
BCDE2BFGH3BMBIJK
Negative life
eventsIM
272272272272272272272272272
Perceived
stress
– scaled














104

304
104

304








Subjective ageBCDE2BFGH3BMBIJK
Subjective life
expectancy/
subj. age
094094094094094094094094
Attitude
toward ageing
071
Age norms070070070070070070070070070070070
WorryingBCDE2BFGH3BMBIJK
Worrying
– scaled



136
336









THEME SOCIAL
AffiliationBCDE2BFGH3BMBIJK
Need for
affiliation


– Scaled
078



278








078



278


141

341






141

341
























HousingBCDE2BFGH3BMBIJK
Housing
characteristics







Adaptations in
the house
014

015





014
014

015

601

601


014
014

015

601

701

014
014

015

601

701

014
014

015





014
014

015

601

701

014
014

015

601

701

014
014

015

601

701

014
014

015





014
014

015





014

015

601

701

014
014

015

601

701

014
014

015






014
Relocation



-tel. proxy*

-tel. respondent*
014

015



014

015

601

601

014

015

601

701
014

015

601

701
014

015



014

015

601

701
014

015

601

701
014

015

601

701
014

015









014

015

601

701
014

015

601

701
014

015
Neighborhood
characteristics
015

z095
015

z095
015

z095
015

z095
015

z095
015

z095
015

z095
015

z095
015

z095


z095
015

z095
015

z095
015

z095
Pets in
household
**
012012012012012012012012012012012012
Residence in
1944
**
013
Partner relationshipBCDE2BFGH3BMBIJK
Relationship quality139139139139139139139139
Relationships
between
generations
BCDE2BFGH3BMBIJK
Parental data**140140
Children**048

048



048

248
048

248
048

248
048



048

248
048

248
048





Filial
responsibility
expectations IM

– scaled








132



332
132



332




























132



332




Vignettes about
help


total scores






074


274






























Grandchildren**049
Social networkBCDE2BFGH3BMBIJK
Personal
network

– network size
047


247
047


247
047


247
047


247
047


247
047


247
047


247
047


247

047


247



047


247
047


247
Contact network167167167
LonelinessBCDE2BFGH3BMBIJK
Loneliness

-scaled

-tel. respondent*

Existental
loneliness
073

273




073

273




073

273




073

273




073

273




073

273




073

273




073

273


712


073

273




073

273




073

273


712


073

273


712

173
073

273



173
Social
participation
BCDE2BFGH3BMBIJK
Social
participation

070

125
070

125
070

125
070

125
070

125
070

125
070

125
070

070

070

070

070

070

Environmental
influence
**
121121121
Social normsBCDE2BFGH3BMBIJK
Values and
norms
**
122122122122122122122122122122122122
Social
desirability**

– scaled



130


330









130


330





















Social
identity**

– scaled






131


331
131


331



























 Donorship**
 – – – – – – – – – – 128128
Ties with
country of origin
**
069
THEME WORK
Work and
Retirement
characteristics
 
Work and
Retirement
– tel. respondent
*
016

016

016

016

016

016

016

016

016

016


016

713
016

713
Physical and
psychosocial
General
Population Job
Exposure Matrix
(GPJEM)

016016016016016016016016016 016016016
Work Perception

106 106106106
THEME PHYSICAL
Blood pressureBCDE2BFGH3BMBIJK
Blood pressure/
pulse
– retests
151

151

151

151

151

151
151

151

151
151

151
151

151
151

151

151
151

151
Body compositionBCDE2BFGH3BMBIJK
Anthropometry

– Weight and height

– Calf measurement

– Ankle, Knee and
Pulse width

161

161

171

161

161



185
161

161

171

161

161

171

161

161

171

161

161

171

161

161

171

161

161

171

161

161

171

161

161




161

161

161


161

161

161


Weight and height
history and
weight change
IM

– tel. respondent*

160



160



160



160



160



160



160



160



160



160



160



714

160



714
Bio-electrical
impedance**
(subsample)

172 –
Birth weight
134134134 –
Perceived body
shape**
– scaled











145

345
145

345



145

345
145

345




DXA
(LASA ancillary study)
– Hip / lumbar spine scan
– Whole body scan





o41
o42


o41
o42



























Chronic diseasesBCDE2BFGH3BMBIJK
Self-report of
chronic diseasesIM

– nr. of diseases
reported

– tel. proxy*

– tel. respondent*

– longitudinally
cleaned

035


235







435
035


235



602

602


435
035


235



602

702


035


235



602

702


035


235







035


235



602

702


035


235



602

702


035


235



602

702


035


235







035


235







035


235



602

702


035


235



602

702


GP informationg01g01g01g01g01g01g01UCUC
Aortic calcification
(lateral radiographs)

zo22zo22
Diabetes mellitus
(algorithm)

zdc1zdc1zdc1zdc1zdc2zdc1
zdc2
zdc1
zdc2
zdc1
zdc2


zdc3
zdc1
zdc2
zdc3
UC
Rheumatoid
Arthritis
(algorithm)

UC
Osteoarthritis hip
and knee
(algorithm)

zoa1
zoa1zoa1 zoa1zoa2zoa1
zoa2
zoa1
zoa2
zoa1
zoa2


zoa3
zoa1
zoa2
zoa3
UC
Metabolic
syndrome

ch02
Allostatic Load
(algorithm)

X
Cardiovascular
diseases
(algorithm)

zh01zh01zh01
Parkinson: early P.
related signs**

096096
Decubitus
(bedsores)

116

159






















Hyperthyroidism**
182 182
Back pain182
182
182
Bedridden
182182
182
182
182
182
FertilityBCDE2BFGH3BMBIJK
Fertility (women)
119 1811 181 181
181
FallingBCDE2BFGH3BMBIJK
Falls

– tel. proxy*

– tel. respondent*

– Falls last year









605

605

187


605

705

187




































187






187












187
Falls: circumstances and
consequences

187
Falls: environmental
conditions (home)**

180
180
Falls: fear of falling
(FES: Falls Efficacy
Scale)

183
183
Falls: prevention of
fall accidents
(LASA ancillary study)

X
Falls: 3y prospective
fall calendar
(LASA ancillary study)

X
Falls: 1y prospective
fall calendar
(LASA ancillary study)

X
DizzinessIM
187
187
187
187
187
187
187
187
187
Adjustments and
walking aids**

187187187187187187187 –
Foot problems
185185185185– 
FracturesBCDE2BFGH3BMBIJK
Fractures

– total waves b-f

– per wave

– tel. proxy*

– tel. respondent*


zo13







zo13

186

605

605


zo13

186

605

705


zo13

186

605

705


zo13

186





zo13

186

605

705





186

605

705






186

605

705






186







186







186

605

705






186

605

705

Vertebral
deformities

zo22zo22
Quantitative
ultrasound of bone

o31o31
Frailty
BCDE2BFGH3BMBIJK
Various definitions
(e.g., frailty
phenotype,
frailty index)

XX  X  X  X  X   X  XXXXX
LifestyleBCDE2BFGH3BMBIJK
Alcohol useIM
– scaled
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
Diet and food
consumption


Lifestyle study
(LASA ancillary study)


Nutrition and
food-related
behaviour
(LASA ancillary study)


with subtopics:
– Eating patterns
– Weight(loss) and appetite
– Mindful eating
– Meals and snack
– Interoceptive awareness of hunger
and satiety
– Alexithymia
– Binge eating
– Eating styles
– Problems food intake
– Use of amenities
– Food products for older adults
– Dietary recommendations
– Sustainable behaviour
– Change in sleep and change in
appetite
118


118
184

118
184










X



118








118


118


MicMac study
(LASA ancillary study)

X
Oral health
X2126
126
Physical activityIM
046
046 046 046 046 046 046 046 046 046 046 046
Daily Physical Activity** 162
Early life physical
activity

246
Perceived physical
activity (LIVAS)
– scaled
114

314
114

314
114

314
114

314
114

314
114

314












 –

Accelerometry
(LASA ancillary studies)
– subsample (St. 1)
– subsample (St. 2)
– subsample (St. 3)
– subsample (St. 4)

































X2





X






X3


















X
 





Sedentary behavior
– scaled
– scaled













101
301
501
101
301
501
101
301
501
101
301
501
101
301
501
101
301
501
SmokingIM
154154154154154154154154154154154154
Medication/
supplements
BCDE2BFGH3BMBI4JK
Medication and
food supplement
use4
– types of
medication

152


352
152


352
152


352
152


352
152


352
152


352
152


352
152


352
152


352
152


352
152


352
152


352
Food supplement
use4
– Vitamin D use
included





















174

374
174

374
PainBCDE2BFGH3BMBIJK
Subjective painIM

– scaled

115

315

115

315

115

315

115

315

115

315

115

315

115

315

115

315

115

315

115

315

115

315

 115

315

Dealing with pain**
188
 
Pain drawing
188
 
Perception:
Vision
BCDE2BFGH3BMBIJK
Vision (self-report)IM
– total scores
– tel. proxy*
– tel. respondent*

031
231



031
231

604
604
031
231

604
704
031
231

604
704
031
231



031
231

604
704
031
231

604
704
031
231

604
704
031
231



031
231



031
231

604
704
031
231

604
704
Visual acuity test

– Vision-related
quality of life







191

192



191

192
191

192
191

192
191





 –

Vision: contrast
sensitivity

157157157157157157
Perception:
Hearing
BCDE2BFGH3BMBIJK
Hearing (self-report)IM
– total scores
– tel. proxy*
– tel. respondent*

031
231



031
231

604
604
031
231

604
704
031
231

604
704
031
231



031
231

604
704
031
231

604
704
031
231

604
704
031
231



031
231



031
231

604
704
031
231
604
704
Hearing: Speech
in Noise Test (SNT)

Hearing: SNT
questions









193


194



193


194
193


194









193


194



Perception: smellBCDE2BFGH3BMBIJK
Olfactory function
S00
S01
S02
S00
S01
S02
Physical
functioning
BCDE2BFGH3BMBIJK
Functional limitations (ADL)IM
– constructed
– tel. proxy*
– tel. respondent*


Use of assistive devices or assistance

Limitations in joint mobility

Functional limitations partner (ADL)
030
230




030



030
230

603
603


030

183


030
230

603
703

030

183

030
230

603
703

030

183

139
030
230




030



030
230

603
703

030



139
030
230

603
703

030



139
030
230

603
703

030



139
030
230




030



139
030
230




030



030
230

603
703

030



139
030
230

603
703

030



139
Global Activity Limitations**

– tel. respondent*
033

033

603
033

703
033

703
033

033

703
033

703
033

703
033



033

703
033

703
Physical
performance

034034034034034034034034034034034 034
Pulmonary function test
– Peak Flow

– Spirometry (post
bronchodilator)

158

158

158

158





158

158



168






Grip strength
161161161161161161161161161161 161
Quality of life
BCDE2BFGH3BMBIJK
EuroQol
– scaled




135
335

135
335
135
335
135
335
135
335

135
335

Qualeffo-41
– (non)response
– Qualeffo scores
– scaled







o80
o81
o82
















SF-12 Health Survey
– scaled
– scaled (Am.)





133
333
533
133
333
533


133
333
533
133
333
533
133
333
533
133
333
533


133
333
533
133
333
533
WHO Quality of Life**
133
133
Self-rated health
– GHPQ
– GHPQ: scaled
– tel. proxy*
– tel. respondent*

036
113
313


036
113
313

602
602
036
113
313

602
702
036
113
313

602
702
036
113
313


036
113
313

602
702
036
113
313

602
702
036
113
313

602
702
036
113
313


036


036


602
702
036


602
702
LASA-wave BCDE2BFGH3BMBIJK